Health & Medical Archives | Page 33 of 242 | Be Korea-savvy

Archive by category Health & Medical

Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain

Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain

RIYADH, Saudi Arabia, Feb. 05, 2024 (Korea Bizwire) – In a major scientific breakthrough, a research team from King Faisal Specialist Hospital and Research Centre (KFSH&RC), in collaboration with King Abdullah University of Science and Technology (KAUST), working alongside researchers from the UK, the US, and India, discovered a vital gene instrumental in combating malaria. [...]

Blue California Completes Groundbreaking Human Clinical Trial on ErgoActive® Ergothioneine Intervention for Cognitive Function, Memory, and Sleep

Blue California Completes Groundbreaking Human Clinical Trial on ErgoActive® Ergothioneine Intervention for Cognitive Function, Memory, and Sleep

Rancho Santa Margarita, Calif., Feb. 05, 2024 (Korea Bizwire) – Blue California, an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine. A double-blinded placebo-controlled clinical trial sponsored by Blue California has shown that ErgoActive® ergothioneine supports aspects of cognitive function, memory, and sleep in healthy elderly subjects with [...]

Junshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences Authority

Junshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences Authority

SHANGHAI, China, Feb. 01, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Singapore Health Sciences Authority (“HSA”) had accepted the New Drug Application (“NDA”) for toripalimab, both in combination with [...]

Sandoz Announces Changes in the Board of Directors

Sandoz Announces Changes in the Board of Directors

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Graeme Pitkethly nominated as candidate for election to the Sandoz Board of Directors at the upcoming Annual General Meeting François-Xavier Roger announced to pursue a new executive responsibility and therefore to step down from the Sandoz Board of Directors post publication [...]

New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

Latest innovation has the potential to reduce anesthesia during minimally invasive procedures [1] As a pioneer and leading innovator in cardiac ultrasound, Philips has developed the smaller X11- 4t Mini 3D TEE transducer to serve more patients with this valuable imaging tool, from pediatric patients to older adults and everyone in between Amsterdam, the Netherlands, January [...]

Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Jan. 31, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Guggenheim Healthcare Talks 6th Annual Biotechnology Conference: Zymeworks’ management will [...]

Sandoz Launches First and Only Biosimilar for Multiple Sclerosis, Tyruko® (natalizumab), in Germany

Sandoz Launches First and Only Biosimilar for Multiple Sclerosis, Tyruko® (natalizumab), in Germany

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE             Tyruko® approved for all indications of reference medicine             Tyruko® biosimilar to treat adults with highly active relapsing remitting multiple sclerosis (RRMS)             Launch strengthens well-established Sandoz biosimilar portfolio in Europe Basel, January 31, 2024 (Korea Bizwire) – [...]

International Barcode of Life Will Change the World

International Barcode of Life Will Change the World

Dr. Paul Hebert receives Benjamin Franklin Medal for revolutionary work Guelph, Ontario, Canada, Jan. 30, 2024 (Korea Bizwire) – Dr. Paul Hebert, the University of Guelph evolutionary biologist who pioneered the field of DNA barcoding, has won the Benjamin Franklin Medal for Earth and Environmental Sciences for 2024. Known as “the father of DNA barcoding,” Hebert [...]

OPEN X Health Launches to Provide Data-driven Creativity to the Pharmaceutical Industry

OPEN X Health Launches to Provide Data-driven Creativity to the Pharmaceutical Industry

January 30, 2024, London, UK (Korea Bizwire) – OPEN Health has launched OPEN X Health, a new practice focused on providing data-driven creativity to the pharmaceutical industry. OPEN X Health (OPEN X) launches after two years of investment and growth in the creative communications offering from OPEN Health. OPEN Health acquired ARK, the award-winning London-based healthcare agency, in [...]

KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award

KFSH&RC-Madinah Receives Prestigious 2023 Press Ganey Human Experience Guardian of Excellence Award

RIYADH, Saudi Arabia, Jan. 29, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSH&RC) in Madinah has won the 2023 Human Experience Guardian of Excellence Award by Press Ganey for its exceptional performance in outpatient services throughout the past year. This prestigious recognition honored a distinguished group of healthcare institutions, from approximately [...]